Pharmacokinetic-Pharmacodynamic Modelling of the Antipyretic Effect of Two Oral Formulations of Ibuprofen

By Trocóniz I.F.  

Clinical Pharmacokinetics, Vol. 38, Iss. 6, 2000-06 ,pp. : 505-518

Adis International

Access to resources Recommend Favorite

Biomarkers, Validation and Pharmacokinetic-Pharmacodynamic Modelling

By Colburn W.A.  

Clinical Pharmacokinetics, Vol. 42, Iss. 12, 2003-01 ,pp. : 997-1022

Adis International

Access to resources Recommend Favorite

Pharmacokinetic/Pharmacodynamic Modelling in Diabetes Mellitus

By Landersdorfer Cornelia B.   Jusko William J.  

Clinical Pharmacokinetics, Vol. 47, Iss. 7, 2008-01 ,pp. : 417-448

Adis International

Access to resources Recommend Favorite

Methodological Issues in Pharmacokinetic-Pharmacodynamic Modelling

By Bellissant E.  

Clinical Pharmacokinetics, Vol. 35, Iss. 2, 1998-08 ,pp. : 151-166

Adis International

Access to resources Recommend Favorite

Preclinical Pharmacology of Bilastine, a New Selective Histamine H1 Receptor Antagonist: Receptor Selectivity and in Vitro Antihistaminic Activity

By Corcóstegui Reyes   Labeaga Luis   Innerárity Ana   Berisa Agustin   Orjales Aurelio  

Drugs in R&D, Vol. 6, Iss. 6, 2005-01 ,pp. : 371-384

Adis International

Access to resources Recommend Favorite